Coexistence of MCR-1 and NDM-1 in Clinical Escherichia coli Isolates

Clinical Infectious Diseases

Volumn 63, Issue 10, 2016, Pages 1393-1395

  Zheng, Beiwen ^a   Dong, Huihui ^a   Xu, Hao ^a   Lv, Jifang ^a   Zhang, Jing ^a,b   Jiang, Xiawei ^c   Du, Yu ^d   Xiao, Yonghong ^a   Li, Lanjuan ^a  

^a Treatment of Infectious Diseases ^*  (China)

^b ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^c ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^d ZHEJIANG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; LEVOFLOXACIN; ANTIINFECTIVE AGENT; BETA LACTAMASE; BETA-LACTAMASE NDM-1; COLISTIN; ESCHERICHIA COLI PROTEIN; MCR-1 PROTEIN, E COLI;

ADULT; ANTIBIOTIC THERAPY; BACTERIAL GENE; BACTERIUM ISOLATION; BLOOD CULTURE; BLOODSTREAM INFECTION; CASE REPORT; CLONAL SPECIES; DYSPNEA; ESCHERICHIA COLI; FEVER; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; INFANT; LETTER; MALE; MEDIATED COLISTIN RESISTANCE GENE; MIDDLE AGED; NEW DELHI METALLO BETA LACTAMASE 1 GENE; NEWBORN SEPSIS; PRIORITY JOURNAL; TRAFFIC ACCIDENT; UNIVERSITY HOSPITAL; ANTIBIOTIC RESISTANCE; ESCHERICHIA COLI INFECTION; PLASMID;

ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; COLISTIN; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI PROTEINS; PLASMIDS;

EID: 84994444360     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/ciw553     Document Type: Letter

References (10)

1. de Jager P, Chirwa T, Naidoo S, Perovic O, Thomas J. Nosocomial outbreak of New Delhi metallo-betalactamase-1-producing gram-negative bacteria in South Africa: a case-control study. PLoS One 2015; 10:e0123337.
2. Jain A, Hopkins KL, Turton J, et al. NDM carbapenemases in the United Kingdom: an analysis of the first 250 cases. J Antimicrob Chemother 2014; 69:1777-84.
3. Liu YY, Wang Y, Walsh TR, et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16:161-8.
4. Gu DX, Huang YL, Ma JH, et al. Detection of colistin resistance gene mcr-1 in hypervirulent Klebsiella pneumoniae and Escherichia coli isolates from an infant with diarrhea in China. Antimicrob Agents Chemother 2016; 60:5099-100.
5. Kim YA, Qureshi ZA, Adams-Haduch JM, Park YS, Shutt KA, Doi Y. Features of infections due to Klebsiella pneumoniae carbapenemase-producing Escherichia coli: emergence of sequence type 131. Clin Infect Dis 2012; 55:224-31.
6. Zhao L, Zhang J, Zheng B, et al. Molecular epidemiology and genetic diversity of fluoroquinoloneresistant Escherichia coli isolates from patients with community-onset infections in 30 Chinese county hospitals. J Clin Microbiol 2015; 53:766-70.
7. Li A, Yang Y, Miao M, et al. Complete sequences of mcr-1-harboring plasmids from extended spectrum beta-lactamase (ESBL)-and carbapenemase-producing Enterobacteriaceae (CPE). Antimicrob Agents Chemother 2016; 60:4351-4.
8. Yao X, Doi Y, Zeng L, Lv L, Liu JH. Carbapenemresistant and colistin-resistant Escherichia coli coproducing NDM-9 and MCR-1. Lancet Infect Dis 2016; 16:288-9.
9. Pournaras S, Koumaki V, Spanakis N, Gennimata V, Tsakris A. Current perspectives on tigecycline resistance in Enterobacteriaceae: susceptibility testing issues and mechanisms of resistance. Int J Antimicrob Agents 2016; 48:11-8.
10. Bogdanovich T, Adams-Haduch JM, Tian GB, et al. Colistin-resistant, Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae belonging to the international epidemic clone ST258. Clin Infect Dis 2011; 53:373-6.